Effect of Jadwar capsules in multiple sclerosis patients

Phase 2

• Conditions: Condition 1: Multiple sclerosis. Condition 2: Fatigue.; Multiple sclerosis; Fatigue; F48.0

• Registration Number: IRCT20200128046288N5
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

MS has been proven by clinical examinations and medical history
Having stable and regular drug treatment in the last 4 weeks
No new attack in last month
Having a score of EDSS disability assessment between 2 to 5.5

Exclusion Criteria

Pregnancy and lactation
Renal and hepatic dysfunction
Neurologic disease in addition to MS
Cardiovascular disease or infectious disease
Allergy to Jadwar

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue rate. Timepoint: The first day of intervention and three months later. Method of measurement: FSS questionnaires.;Quality of Life. Timepoint: The first day of intervention and three months later. Method of measurement: Questionnaire MSQL54.

Secondary Outcome Measures

Name	Time	Method
Side effects of the drug. Timepoint: Three months after the start of the intervention. Method of measurement: Observation.